Peter Barry: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
m (Text replacement - "|first4=" to " | first4 = ")
m (Text replacement - "last = " to "last = ")
 
(10 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{NeedsImage}}
{{NeedsImage}}
'''Peter Barry''' is a consultant pediatrician and lecturer in child health in Leicester, East Midlands, [[UK]]. He is a prolific researcher and has published over 60 articles or books.<ref>{{Cite web|url=https://www.le.ac.uk/childhealth/staff/pwb1.html|title=Peter Barry {{!}} Child Health {{!}} University of Leicester | last=University of Leicester | first = | date = |website=|archive-url=|archive-date=|url-status=|access-date= October 28,  2018}}</ref><ref name=":0">{{Cite web|url=http://www.eastmidlandscongenitalheart.nhs.uk/what-we-do/our-fantastic-teams/intensive-care/peter-barry/|title=Peter Barry {{!}} Our specialist care teams {{!}} East Midlands NHS Trust|last= | first = | date = |website=|archive-url=|archive-date=|url-status=|access-date=}}</ref>
'''Peter Barry''' is a consultant pediatrician and lecturer in child health in Leicester, East Midlands, [[UK]]. He is a prolific researcher and has published over 60 articles or books.<ref>{{Cite web|url=https://www.le.ac.uk/childhealth/staff/pwb1.html | title = Peter Barry {{!}} Child Health {{!}} University of Leicester | last=University of Leicester | first = | date = |website=|archive-url=|archive-date=|url-status=|access-date= October 28,  2018}}</ref><ref name=":0">{{Cite web|url=http://www.eastmidlandscongenitalheart.nhs.uk/what-we-do/our-fantastic-teams/intensive-care/peter-barry/ | title = Peter Barry {{!}} Our specialist care teams {{!}} East Midlands NHS Trust | last = | first = | date = |website=|archive-url=|archive-date=|url-status=|access-date=}}</ref>


Peter Barry, also known as Peter W. Barry, was been appointed Chair of the review panel for the [[CFS/ME]] [[NICE guidelines]] review, which strongly influences [[NHS]] treatment for people with [[ME/CFS]] in the UK.<ref>{{Cite web|url=https://www.nice.org.uk/guidance/gid-ng10091/documents/committee-member-list|title=Committee member list {{!}} NICE CG53 CFS/ME guidance update|last=[[NICE]] | first = | date = October 28,  2018 | website = nice.org.uk|archive-url=|archive-date=|url-status=|access-date=20 October 2018}}</ref> He has been a member of a number of different NICE review panels in recent years.<ref name=":1">{{Cite journal | last = Tan | first = Toni | last2 = Barry | first2 = Peter | last3 = Reken | first3=Stefanie|last4 = Baker | first4=Mark|date=2010-03-24|title=Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance|url=https://www.bmj.com/content/340/bmj.c1079|journal=BMJ|language=en|volume=340|pages=c1079|doi=10.1136/bmj.c1079|issn=0959-8138|pmid=20335333}}</ref><ref name=":2">{{Cite journal|last=Rabar | first = Silvia | last2 = Lau | first2 = Rosa | last3 = O'Flynn | first3=Norma|last4 = Li | first4 = Lilian | last5 = Barry|first5=Peter|date=2012-08-08|title=Risk assessment of fragility fractures: summary of NICE guidance|url=https://www.bmj.com/content/345/bmj.e3698|journal=BMJ|language=en|volume=345| pages = e3698|doi=10.1136/bmj.e3698|issn=1756-1833|pmid=22875946}}</ref>
Peter Barry, also known as Peter W. Barry, was been appointed Chair of the review panel for the [[CFS/ME]] [[NICE guidelines]] review, which strongly influences [[NHS]] treatment for people with [[ME/CFS]] in the UK.<ref>{{Cite web|url=https://www.nice.org.uk/guidance/gid-ng10091/documents/committee-member-list | title = Committee member list {{!}} NICE CG53 CFS/ME guidance update | last = [[NICE]] | first = | date = October 28,  2018 | website = nice.org.uk|archive-url=|archive-date=|url-status=|access-date=20 October 2018}}</ref> He has been a member of a number of different NICE review panels in recent years.<ref name=":1">{{Cite journal | last = Tan | first = Toni | last2 = Barry | first2 = Peter | last3 = Reken | first3 = Stefanie | last4 = Baker | first4 = Mark | date = 2010-03-24 | title = Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance|url=https://www.bmj.com/content/340/bmj.c1079|journal=BMJ|language=en|volume=340|pages=c1079|doi=10.1136/bmj.c1079|issn=0959-8138|pmid=20335333}}</ref><ref name=":2">{{Cite journal | last = Rabar | first = Silvia | last2 = Lau | first2 = Rosa | last3 = O'Flynn | first3 = Norma | last4 = Li | first4 = Lilian | last5 = Barry | first5 = Peter | date = 2012-08-08 | title = Risk assessment of fragility fractures: summary of NICE guidance|url=https://www.bmj.com/content/345/bmj.e3698|journal=BMJ|language=en|volume=345| pages = e3698|doi=10.1136/bmj.e3698|issn=1756-1833|pmid=22875946}}</ref>


==Notable studies==
==Notable studies==
Line 8: Line 8:
2010 - Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance<ref name=":1" />
2010 - Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance<ref name=":1" />


2011 Diagnosis and assessment of food [[allergy]] in children and young people: summary of NICE guidance<ref>{{Cite journal|last=Sackeyfio | first = A | last2 = Senthinathan | first2=A | last3 = Kandaswamy | first3 = P|last4 = Barry | first4 = P W | last5 = Shaw|first5=B | last6 = Baker | first6=M | date = 2011 | title = GUIDELINES: Diagnosis and assessment of food allergy in children and young people: summary of NICE guidance |url=http://www.jstor.org/stable/41150646 | journal = BMJ: British Medical Journal |volume=342|issue=7796 | pages = 544–546}}</ref>
2011 Diagnosis and assessment of food [[allergy]] in children and young people: summary of NICE guidance<ref>{{Cite journal | last = Sackeyfio | first = A | last2 = Senthinathan | first2 = A | last3 = Kandaswamy | first3 = P | last4 = Barry | first4 = P W | last5 = Shaw | first5 = B | last6 = Baker | first6 = M | date = 2011 | title = GUIDELINES: Diagnosis and assessment of food allergy in children and young people: summary of NICE guidance |url=http://www.jstor.org/stable/41150646 | journal = BMJ: British Medical Journal |volume=342|issue=7796 | pages = 544–546}}</ref>


2012 - Risk assessment of fragility fractures: summary of NICE guidance<ref name=":2" />
2012 - Risk assessment of fragility fractures: summary of NICE guidance<ref name=":2" />


2017 - Pediatric Intensive Care (book)<ref>{{Cite book |url=https://books.google.co.uk/books?hl=en&id=XOI-DgAAQBAJ&oi=fnd&pg=PR11|title=Paediatric Intensive Care|last=Barry | first = Peter | last2 = Morris | first2=Kevin | last3 = Ali | first3 = Tariq|date=2017-05-25|publisher=Oxford University Press|isbn=9780198807018|language=en}}</ref>
2017 - Pediatric Intensive Care (book)<ref>{{Cite book |url=https://books.google.co.uk/books?hl=en&id=XOI-DgAAQBAJ&oi=fnd&pg=PR11 | title = Paediatric Intensive Care | last = Barry | first = Peter | last2 = Morris | first2 = Kevin | last3 = Ali | first3 = Tariq | date = 2017-05-25|publisher=Oxford University Press|isbn=9780198807018|language=en}}</ref>


==Clinic location==
==Clinic location==

Latest revision as of 21:12, March 30, 2023

Peter Barry is a consultant pediatrician and lecturer in child health in Leicester, East Midlands, UK. He is a prolific researcher and has published over 60 articles or books.[1][2]

Peter Barry, also known as Peter W. Barry, was been appointed Chair of the review panel for the CFS/ME NICE guidelines review, which strongly influences NHS treatment for people with ME/CFS in the UK.[3] He has been a member of a number of different NICE review panels in recent years.[4][5]

Notable studies[edit | edit source]

2010 - Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance[4]

2011 Diagnosis and assessment of food allergy in children and young people: summary of NICE guidance[6]

2012 - Risk assessment of fragility fractures: summary of NICE guidance[5]

2017 - Pediatric Intensive Care (book)[7]

Clinic location[edit | edit source]

Talks and interviews[edit | edit source]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. University of Leicester. "Peter Barry | Child Health | University of Leicester". Retrieved October 28, 2018.
  2. "Peter Barry | Our specialist care teams | East Midlands NHS Trust".
  3. NICE (October 28, 2018). "Committee member list | NICE CG53 CFS/ME guidance update". nice.org.uk. Retrieved October 20, 2018.
  4. 4.0 4.1 Tan, Toni; Barry, Peter; Reken, Stefanie; Baker, Mark (March 24, 2010). "Pharmacological management of neuropathic pain in non-specialist settings: summary of NICE guidance". BMJ. 340: c1079. doi:10.1136/bmj.c1079. ISSN 0959-8138. PMID 20335333.
  5. 5.0 5.1 Rabar, Silvia; Lau, Rosa; O'Flynn, Norma; Li, Lilian; Barry, Peter (August 8, 2012). "Risk assessment of fragility fractures: summary of NICE guidance". BMJ. 345: e3698. doi:10.1136/bmj.e3698. ISSN 1756-1833. PMID 22875946.
  6. Sackeyfio, A; Senthinathan, A; Kandaswamy, P; Barry, P W; Shaw, B; Baker, M (2011). "GUIDELINES: Diagnosis and assessment of food allergy in children and young people: summary of NICE guidance". BMJ: British Medical Journal. 342 (7796): 544–546.
  7. Barry, Peter; Morris, Kevin; Ali, Tariq (May 25, 2017). Paediatric Intensive Care. Oxford University Press. ISBN 9780198807018.